FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036701561> ?p ?o ?g. }

• W3036701561 abstract "Abstract Objective Chondrosarcoma is the second most common primary bone sarcoma; however, unlike other tumors, the biopsy cannot easily make a definite diagnosis or predict the histological grade. This meta-analysis was performed to evaluate the utility of 18 F-FDG PET and PET/CT to differentiate chondrosarcoma from benign cartilaginous lesions and to predict the histopathological grade of chondrosarcoma. Material and methods A comprehensive search was performed in three electronic databases including Medline/PubMed, the Cochrane Library and Embase to retrieve diagnostic studies evaluating the role of 18 F-FDG PET or PET/CT for appraising the status of chondrosarcoma. Reference lists of related articles were also scrutinized manually. Useful data were extracted to calculate the pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), the summary receiver operating characteristic curve (sROC), and the area under the curve (AUC) of 18 F-FDG PET or PET/CT in diagnosing chondrosarcoma, and pooled weighted mean differences (WMD) of maximum standardized uptake value (SUVmax) between different entities of cartilaginous neoplasms by using Stata 19.0. Results A total of twelve studies provided sufficient data for the quantitative analysis. For the diagnosis of chondrosarcoma, the pooled sensitivity, specificity, and DOR of 18 F-FDG PET were 0.84 (95% confidence interval [CI] 0.46 to 0.97), 0.82 (95% CI 0.55 to 0.94), and 24.244 (95% CI 1.985 to 96.148), respectively while those of 18 F-FDG PET/CT were 0.94 (95% CI 0.86 to 0.97), 0.89 (95% CI 0.82 to 0.93), and 112.999 (95% CI 41.341 to 308.866), respectively. The pooled WMD of SUVmax were − 0.89 (95% CI −1.67 to −0.10) between benign cartilaginous lesions and grade 1 (G1) chondrosarcoma, −1.94 (95% CI −2.76 to −1.12) between G1 and grade 2 (G2) chondrosarcoma, and − 2.37 (95% CI −5.79 to 1.05) between G2 and grade 3 (G3) chondrosarcoma. Conclusions In a word, 18 F-FDG PET/CT revealed excellent accuracy in the diagnosis of chondrosarcoma and might assist in clinical decision-making. Meanwhile, although SUVmax alone showed restricted ability to differentiate benign cartilaginous lesions and G1 chondrosarcoma, as well as between G2 and G3 chondrosarcoma, it can identify intermediate/high-grade chondrosarcoma from low-grade ones. Level of evidence Level I evidence, a summary of meta-analysis" @default.
• W3036701561 created "2020-06-25" @default.
• W3036701561 creator A5050424123 @default.
• W3036701561 creator A5056036725 @default.
• W3036701561 creator A5078181925 @default.
• W3036701561 creator A5084062117 @default.
• W3036701561 creator A5085841639 @default.
• W3036701561 date "2020-06-22" @default.
• W3036701561 modified "2023-10-15" @default.
• W3036701561 title "The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis" @default.
• W3036701561 cites W1966386780 @default.
• W3036701561 cites W1991425438 @default.
• W3036701561 cites W2023392165 @default.
• W3036701561 cites W2033647435 @default.
• W3036701561 cites W2040051511 @default.
• W3036701561 cites W2054813045 @default.
• W3036701561 cites W2081735333 @default.
• W3036701561 cites W2082005551 @default.
• W3036701561 cites W2107638293 @default.
• W3036701561 cites W2114074851 @default.
• W3036701561 cites W2145108791 @default.
• W3036701561 cites W2277548205 @default.
• W3036701561 cites W2292723938 @default.
• W3036701561 cites W2311115843 @default.
• W3036701561 cites W2594743616 @default.
• W3036701561 cites W2606651543 @default.
• W3036701561 cites W2624770063 @default.
• W3036701561 cites W2761276294 @default.
• W3036701561 cites W2773653224 @default.
• W3036701561 cites W2781344467 @default.
• W3036701561 cites W2796881876 @default.
• W3036701561 cites W2800988467 @default.
• W3036701561 cites W2807874191 @default.
• W3036701561 cites W2883493146 @default.
• W3036701561 cites W2911955225 @default.
• W3036701561 cites W2928910253 @default.
• W3036701561 cites W2963209634 @default.
• W3036701561 cites W2968580098 @default.
• W3036701561 cites W2996892691 @default.
• W3036701561 doi "https://doi.org/10.1186/s13018-020-01748-w" @default.
• W3036701561 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7310032" @default.
• W3036701561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32571371" @default.
• W3036701561 hasPublicationYear "2020" @default.
• W3036701561 type Work @default.
• W3036701561 sameAs 3036701561 @default.
• W3036701561 citedByCount "16" @default.
• W3036701561 countsByYear W30367015612021 @default.
• W3036701561 countsByYear W30367015612022 @default.
• W3036701561 countsByYear W30367015612023 @default.
• W3036701561 crossrefType "journal-article" @default.
• W3036701561 hasAuthorship W3036701561A5050424123 @default.
• W3036701561 hasAuthorship W3036701561A5056036725 @default.
• W3036701561 hasAuthorship W3036701561A5078181925 @default.
• W3036701561 hasAuthorship W3036701561A5084062117 @default.
• W3036701561 hasAuthorship W3036701561A5085841639 @default.
• W3036701561 hasBestOaLocation W30367015611 @default.
• W3036701561 hasConcept C126322002 @default.
• W3036701561 hasConcept C126838900 @default.
• W3036701561 hasConcept C127077266 @default.
• W3036701561 hasConcept C142724271 @default.
• W3036701561 hasConcept C144494922 @default.
• W3036701561 hasConcept C156957248 @default.
• W3036701561 hasConcept C157481446 @default.
• W3036701561 hasConcept C2775842073 @default.
• W3036701561 hasConcept C2775934546 @default.
• W3036701561 hasConcept C2776302905 @default.
• W3036701561 hasConcept C2776478404 @default.
• W3036701561 hasConcept C2989005 @default.
• W3036701561 hasConcept C3020132585 @default.
• W3036701561 hasConcept C44249647 @default.
• W3036701561 hasConcept C58471807 @default.
• W3036701561 hasConcept C71924100 @default.
• W3036701561 hasConcept C95190672 @default.
• W3036701561 hasConceptScore W3036701561C126322002 @default.
• W3036701561 hasConceptScore W3036701561C126838900 @default.
• W3036701561 hasConceptScore W3036701561C127077266 @default.
• W3036701561 hasConceptScore W3036701561C142724271 @default.
• W3036701561 hasConceptScore W3036701561C144494922 @default.
• W3036701561 hasConceptScore W3036701561C156957248 @default.
• W3036701561 hasConceptScore W3036701561C157481446 @default.
• W3036701561 hasConceptScore W3036701561C2775842073 @default.
• W3036701561 hasConceptScore W3036701561C2775934546 @default.
• W3036701561 hasConceptScore W3036701561C2776302905 @default.
• W3036701561 hasConceptScore W3036701561C2776478404 @default.
• W3036701561 hasConceptScore W3036701561C2989005 @default.
• W3036701561 hasConceptScore W3036701561C3020132585 @default.
• W3036701561 hasConceptScore W3036701561C44249647 @default.
• W3036701561 hasConceptScore W3036701561C58471807 @default.
• W3036701561 hasConceptScore W3036701561C71924100 @default.
• W3036701561 hasConceptScore W3036701561C95190672 @default.
• W3036701561 hasFunder F4320313681 @default.
• W3036701561 hasIssue "1" @default.
• W3036701561 hasLocation W30367015611 @default.
• W3036701561 hasLocation W30367015612 @default.
• W3036701561 hasLocation W30367015613 @default.
• W3036701561 hasLocation W30367015614 @default.
• W3036701561 hasLocation W30367015615 @default.
• W3036701561 hasOpenAccess W3036701561 @default.
• W3036701561 hasPrimaryLocation W30367015611 @default.
• W3036701561 hasRelatedWork W2416466220 @default.

• next